PCSA

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) is a clinical-stage biopharmaceutical company founded in 2011 and based in Hanover, Maryland. The company went public in March 2014 and focuses on developing innovative drug products to address unmet medical needs, particularly in oncology and gastrointestinal disorders. Processa operates as a development-stage company with no current revenue, relying on clinical trials to advance its pipeline of potential therapeutic treatments through regulatory approval processes.